Becton, Dickinson and Company (BDX) vs Teva Pharmaceutical Industries Limited (TEVA)
A side-by-side comparison of Becton, Dickinson and Company and Teva Pharmaceutical Industries Limited across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of August 28, 2026. Differences are shown without an overall score or investment verdict.
BDX
Becton, Dickinson and Company
$189.28HealthcareDelayed quote: Aug 28, 2026, 12:20 PM EDT
TEVA
Teva Pharmaceutical Industries Limited
$36.63HealthcareDelayed quote: Aug 28, 2026, 12:20 PM EDT
Total return — BDX vs TEVA
growth of $100 · dividends reinvested · last 10yBDX +62.0% (+4.9%/yr)TEVA -23.4% (-2.6%/yr)BDX compounded faster over this window
BDX TEVA
BDX vs TEVA: by the numbers
- •BDX is the larger company ($52.15B vs $42.66B market cap).
- •BDX trades at the lower trailing earnings multiple (56.67 vs 62.70 P/E), one valuation lens rather than an overall verdict.
- •BDX converts more revenue to profit (4.52% vs 4.08% net margin).
- •BDX pays a dividend (1.99% yield), while TEVA is a former payer with no current dividend run rate.
Metrics side by side
Valuation
| Metric | BDX | TEVA |
|---|---|---|
| P/E ratio | 56.67 | 62.70 |
| Forward P/E | 14.85 | 18.80 |
| P/S ratio | 2.48 | 2.57 |
| P/B ratio | 2.12 | 5.73 |
| EV / EBITDA | 12.32 | 19.40 |
| FCF yield | 5.04% | 3.03% |
Profitability
| Metric | BDX | TEVA |
|---|---|---|
| Gross margin | 46.12% | 52.47% |
| Operating margin | 9.83% | 11.45% |
| Net margin | 4.52% | 4.08% |
| ROE | 3.85% | 9.10% |
| ROIC | 3.72% | 6.79% |
Dividends
| Metric | BDX | TEVA |
|---|---|---|
| Dividend yield | 1.99% | N/A |
| Payout ratio | 64.09% | N/A |
Growth (annualized)
| Metric | BDX | TEVA |
|---|---|---|
| Revenue CAGR (5Y) | 1.22% | 1.19% |
| EPS CAGR (5Y) | 16.26% | N/A |
| FCF CAGR (5Y) | -9.10% | 14.58% |
| Total return CAGR (5Y) | 1.53% | 32.11% |
Frequently asked
- Which has the lower trailing P/E, BDX or TEVA?
- BDX has the lower trailing P/E: BDX trades at 56.67 and TEVA at 62.70. P/E is one valuation measure and does not by itself establish which business is cheaper.
- Which has grown faster, BDX or TEVA?
- Over the past five years, BDX grew revenue faster — BDX at a 1.22% CAGR versus TEVA at 1.19%.
- Does BDX or TEVA pay a bigger dividend?
- BDX pays a dividend (1.99% yield), while TEVA is a former payer with no current dividend run rate.
- Is BDX or TEVA more profitable?
- BDX runs the higher net margin — BDX at 4.52% versus TEVA at 4.08%.
- How have BDX and TEVA total returns compared?
- Over the past 10 years, BDX delivered 5.05% and TEVA delivered -2.70% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Becton, Dickinson P/E ratioTeva Pharmaceutical Industries P/E ratioBecton, Dickinson dividend yieldBecton, Dickinson ROETeva Pharmaceutical Industries ROEBecton, Dickinson operating marginTeva Pharmaceutical Industries operating marginBecton, Dickinson revenue growthTeva Pharmaceutical Industries revenue growthBecton, Dickinson free cash flowTeva Pharmaceutical Industries free cash flow
Becton, Dickinson & Teva Pharmaceutical Industries appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified August 28, 2026.